These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26022117)

  • 1. Duloxetine Hydrochloride-Induced Oral Lichenoid Reaction: A Case Report.
    Kadam NS; Patil RA; Gurav AN; Shete A; Jadhav PD; Naik Tari R; Metkari S; Agarwal D
    Med Princ Pract; 2015; 24(4):394-7. PubMed ID: 26022117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature.
    Štuhec M
    Wien Klin Wochenschr; 2015 Sep; 127(17-18):703-6. PubMed ID: 25576334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lichenoid eruptions of the mouth mucosa induced by lithium carbonate. 2 cases].
    Menni S; Barbareschi M; Fargetti G; Hendrickx I
    Ann Dermatol Venereol; 1995; 122(3):91-3. PubMed ID: 7486729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
    Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
    J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
    [No Abstract]   [Full Text] [Related]  

  • 5. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
    Gicquel C; Moulis F; Chenaf C; Gouraud A; Drici M; Bondon-Guitton E; Montastruc F; Montastruc JL
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1197-1198. PubMed ID: 28639120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intraoperative floppy iris syndrome after treatment with duloxetine: coincidence, association, or causality?].
    González-Martín-Moro J; González-López JJ; Zarallo-Gallardo J; Fernández-Miguel Y
    Arch Soc Esp Oftalmol; 2015 Feb; 90(2):94-6. PubMed ID: 25443465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of retrobulbar optic neuritis caused by duloxetine.
    Bicer T; Kosker M; Celikay O; Gurdal C
    Cutan Ocul Toxicol; 2016 Sep; 35(3):251-3. PubMed ID: 26362493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status Cataplecticus Induced by an Abrupt Duloxetine Withdrawal-A Case Report.
    Cierny M; Feemster J; Hamid M; Battistini HA
    Clin Neuropharmacol; 2023 Sep-Oct 01; 46(5):198-199. PubMed ID: 37748003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
    Kassam AS; Cunningham EA; Musco SE
    Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30916900
    [No Abstract]   [Full Text] [Related]  

  • 10. Duloxetine-related posterior reversible encephalopathy syndrome: A case report.
    Zappella N; Perier F; Pico F; Palette C; Muret A; Merceron S; Girbovan A; Marquion F; Legriel S
    Medicine (Baltimore); 2016 Aug; 95(33):e4556. PubMed ID: 27537580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced movement disorder and confusion associated with duloxetine.
    Siddiqui SH; Memon NA; Shanker R
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29592972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-Associated Microscopic Colitis: A Case Report and Literature Review.
    Salter TG; Williams MD
    Psychosomatics; 2017; 58(3):307-312. PubMed ID: 28347506
    [No Abstract]   [Full Text] [Related]  

  • 13. Eosinophilic pneumonia due to duloxetine.
    Espeleta VJ; Moore WH; Kane PB; Baram D
    Chest; 2007 Mar; 131(3):901-903. PubMed ID: 17356112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atraumatic trismus induced by duloxetine: an uncommon presentation of acute dystonia.
    Ohn MH; Loo JL; Ohn KM
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine Induced Hyponatremia.
    Şahan E; Parlakkaya Yıldız FB
    Turk Psikiyatri Derg; 2019; 30(4):287-289. PubMed ID: 32594491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
    Emslie GJ; Wells TG; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):293-305. PubMed ID: 25978741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysosmia and dysgeusia associated with duloxetine.
    Yoshida K; Fukuchi T; Sugawara H
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Duloxetine as Micronuclei Inducer in an Acute and a Subchronic Assay in Mouse.
    Madrigal-Bujaidar E; Álvarez-González I; Madrigal-Santillán EO; Morales-González JA
    Biol Pharm Bull; 2015; 38(8):1245-9. PubMed ID: 26235590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lichenoid tissue reactions: diagnosis and classification.
    Khudhur AS; Di Zenzo G; Carrozzo M
    Expert Rev Mol Diagn; 2014 Mar; 14(2):169-84. PubMed ID: 24524807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term duloxetine withdrawal syndrome and management in a depressed patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E4. PubMed ID: 24515685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.